GlassScriptPhysician profile
Cindy Duong
NPI 1073191656
$7,243.11
in general payments reported to CMS, 2019-2025
16 companies · $3,411 in 2025
The $3,411 reported for 2025 was more than what 90% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.00 · 2022: $568 · 2023: $129 · 2024: $3,117 · 2025: $3,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,542 · Food and Beverage: $2,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,542.48 |
| Food and Beverage | $2,115.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $2,307.21 | 2024 | Truelok |
| Treace Medical Concepts, INC. | $1,695.09 | 2024-2025 | |
| Medical Device Business Services, INC. | $1,323.37 | 2022-2025 | Motoband |
| Stryker Corporation | $488.70 | 2021-2025 | Citrefix, Hoffmann |
| Paragon 28, INC. | $362.54 | 2024 | Additive Orthopedics |
| Smith+Nephew, INC. | $335.73 | 2023-2025 | Stravix Pl, Grafix Pl, Stravix Mesh |
| Kerecis Limited | $177.51 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Sanara Medtech INC. | $149.66 | 2025 | Celleraterx |
| Depuy Synthes Sales INC. | $121.34 | 2025 | Motoband, Dynaforce |
| Paratek Pharmaceuticals, INC. | $100.62 | 2022 | |
| Elite Orthopedics, LLC | $94.84 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $32.09 | 2023 | |
| Paladin Technology Solutions | $15.38 | 2023 | |
| Eclipse Technology Solutions INC. | $14.36 | 2024 | |
| Globus Medical, INC. | $13.74 | 2025 | Senza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kuros Biosciences USA, INC | $10.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Duong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.